project id: TCGA-BLCA; case submitter id: TCGA-GD-A3OQ; analyte type: DNA; selected normal wgs: true; selected normal wxs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; age at index: 48; days to birth: -17682; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 17682; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 95.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 1.6986301369863013; pack years smoked: 31.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0;